# Study of AG-120 in Previously Treated Advanced Cholangiocarcinoma With IDH1 Mutations (ClarIDHy)

> **NCT02989857** · PHASE3 · COMPLETED · sponsor: **Institut de Recherches Internationales Servier** · enrollment: 187 (actual)

## Conditions studied

- Advanced Cholangiocarcinoma
- Metastatic Cholangiocarcinoma

## Interventions

- **DRUG:** AG-120
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02989857
- **Lead sponsor:** Institut de Recherches Internationales Servier
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-20
- **Primary completion:** 2019-01-31
- **Final completion:** 2021-05-17
- **Target enrollment:** 187 (ACTUAL)
- **Last updated:** 2024-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02989857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02989857, "Study of AG-120 in Previously Treated Advanced Cholangiocarcinoma With IDH1 Mutations (ClarIDHy)". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT02989857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*